Ray Dalio's CE Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 155.8K shares of Celanese Corporation (CE) worth $6.55 M, representing 0.03% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Ray Dalio has maintained a long-term strategic position in CE, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2025, adding 154.2K shares. Largest reduction occurred in Q3 2022, reducing 166.4K shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Celanese Corporation (CE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Celanese Corporation (CE) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +14,401 | Add 0.00% | 14,400 | $44.79 |
| Q3 2013 | -3,574 | Reduce 24.82% | 10,826 | $52.84 |
| Q4 2013 | +4,100 | Add 37.87% | 14,926 | $55.34 |
| Q1 2014 | -14,926 | Sold Out | 14,926 | $0.00 |
| Q3 2014 | +7,426 | New Buy | 7,426 | $58.58 |
| Q4 2014 | -4,000 | Reduce 53.86% | 3,426 | $59.84 |
| Q1 2015 | +750 | Add 21.89% | 4,176 | $55.80 |
| Q2 2015 | -4,176 | Sold Out | 4,176 | $0.00 |
| Q3 2015 | +6,976 | New Buy | 6,976 | $59.20 |
| Q4 2015 | -6,976 | Sold Out | 6,976 | $0.00 |
| Q2 2016 | +21,500 | New Buy | 21,500 | $65.44 |
| Q3 2016 | -21,500 | Sold Out | 21,500 | $0.00 |
| Q1 2017 | +4,131 | New Buy | 4,131 | $89.81 |
| Q2 2017 | -4,131 | Sold Out | 4,131 | $0.00 |
| Q1 2018 | +22,564 | New Buy | 22,564 | $100.20 |
| Q2 2018 | -17,231 | Reduce 76.37% | 5,333 | $111.01 |
| Q3 2018 | -5,333 | Sold Out | 5,333 | $0.00 |
| Q4 2018 | +7,378 | New Buy | 7,378 | $90.00 |
| Q1 2019 | +3,657 | Add 49.57% | 11,035 | $98.60 |
| Q2 2019 | -11,035 | Sold Out | 11,035 | $0.00 |
| Q4 2019 | +44,389 | New Buy | 44,389 | $123.12 |
| Q1 2020 | -15,015 | Reduce 33.83% | 29,374 | $73.40 |
| Q2 2020 | -2,087 | Reduce 7.10% | 27,287 | $86.34 |
| Q3 2020 | +4,131 | Add 15.14% | 31,418 | $107.45 |
| Q4 2020 | -31,418 | Sold Out | 31,418 | $0.00 |
| Q1 2021 | +99,730 | New Buy | 99,730 | $149.81 |
| Q2 2021 | +10,634 | Add 10.66% | 110,364 | $151.60 |
| Q3 2021 | +58,375 | Add 52.89% | 168,739 | $150.64 |
| Q4 2021 | -61,627 | Reduce 36.52% | 107,112 | $168.06 |
| Q1 2022 | -39,083 | Reduce 36.49% | 68,029 | $142.87 |
| Q2 2022 | +116,582 | Add 171.37% | 184,611 | $117.61 |
| Q3 2022 | -166,400 | Reduce 90.14% | 18,211 | $90.33 |
| Q4 2022 | -10,817 | Reduce 59.40% | 7,394 | $102.24 |
| Q1 2023 | -7,394 | Sold Out | 7,394 | $0.00 |
| Q2 2024 | +1,511 | New Buy | 1,511 | $134.89 |
| Q3 2024 | -1,511 | Sold Out | 1,511 | $0.00 |
| Q3 2025 | +155,755 | New Buy | 155,755 | $42.08 |
Ray Dalio's Celanese Corporation Investment FAQs
Ray Dalio first purchased Celanese Corporation (CE) in Q2 2013, acquiring 14,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Celanese Corporation (CE) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Celanese Corporation (CE) was in Q3 2025, adding 155,755 shares worth $6.55 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 155,755 shares of Celanese Corporation (CE), valued at approximately $6.55 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Celanese Corporation (CE) represents approximately 0.03% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Celanese Corporation (CE) was 184,611 shares, as reported at the end of Q2 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.